CC
Get informed when a big investor buys or sells
+ FollowOvervalued by 284.9% based on the discounted cash flow analysis.
| Market cap | $1.98 Billion |
|---|---|
| Enterprise Value | $5.37 Billion |
| Dividend Yield | $0.35 (2.73%) |
| Earnings per Share | $-2.57 |
| Beta | 1.4 |
| Outstanding Shares | 151,381,215 |
| P/E Ratio | -6.41 |
|---|---|
| PEG | 22.81 |
| Price to Sales | 0.34 |
| Price to Book Ratio | -12.81 |
| Enterprise Value to Revenue | 0.93 |
| Enterprise Value to EBIT | -7.7 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0.76 |
| Debt to Equity | -82.92 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 45.27% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 1.34%▼ 90.39% |
|---|---|
| Total Invested | $27.90M▼ 99.01% |
| Investors Holding | 94▼ 406.00% |
No data
The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemi...